Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 10:11 am Purchase |
2023-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL |
Mitchell P. Kopin | 2,751 4.990% |
2,751 (New Position) |
Filing History |
| 2024-02-06 10:06 am Purchase |
2023-12-31 | 13G | Aditxt, Inc. ADTX |
Mitchell P. Kopin | 1 1.500% |
1 (New Position) |
Filing History |
| 2024-02-06 10:04 am Unchanged |
2023-12-31 | 13G | DMK Pharmaceuticals Corporation DMKPQ |
Mitchell P. Kopin | 650,000 6.000% |
0 (Unchanged) |
Filing History |
| 2024-02-06 09:56 am Sale |
2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 903,412 9.990% |
-1,015,547 (-52.92%) |
Filing History |
| 2024-02-06 09:52 am Purchase |
2023-12-31 | 13G | Clearmind Medicine Inc. CMND |
Mitchell P. Kopin | 88,925 4.990% |
88,925 (New Position) |
Filing History |
| 2024-02-02 4:10 pm Purchase |
2024-01-25 | 13G | RedHill Biopharma Ltd. RDHL |
Mitchell P. Kopin | 2,000 4.000% |
2,000 (New Position) |
Filing History |
| 2023-11-27 06:10 am Purchase |
2023-11-16 | 13G | Bone Biologics Corporation BBLG |
Mitchell P. Kopin | 28,056 4.990% |
28,056 (New Position) |
Filing History |
| 2023-08-11 4:18 pm Purchase |
2023-08-04 | 13G | NAYA Biosciences, Inc. NAYA |
Mitchell P. Kopin | 15,333 7.100% |
15,333 (New Position) |
Filing History |
| 2023-08-10 4:03 pm Purchase |
2023-08-01 | 13G | DMK Pharmaceuticals Corporation DMKPQ |
Mitchell P. Kopin | 650,000 7.600% |
650,000 (New Position) |
Filing History |
| 2023-07-14 5:27 pm Purchase |
2023-07-06 | 13G | Allarity Therapeutics, Inc. ALLR |
Mitchell P. Kopin | 75 4.990% |
75 (New Position) |
Filing History |
| 2023-06-30 4:10 pm Purchase |
2023-06-22 | 13G | Innovative Eyewear, Inc. LUCY |
Mitchell P. Kopin | 28,470 4.200% |
28,470 (New Position) |
Filing History |
| 2023-06-01 5:23 pm Purchase |
2023-05-23 | 13G | Dermata Therapeutics, Inc. DRMA |
Mitchell P. Kopin | 9,596 4.990% |
9,596 (New Position) |
Filing History |
| 2023-05-25 4:13 pm Purchase |
2023-05-16 | 13G | OncoSec Medical Incorporated ONCS |
Mitchell P. Kopin | 313,158 4.990% |
313,158 (New Position) |
Filing History |
| 2023-04-28 4:31 pm Purchase |
2023-04-19 | 13G | Allarity Therapeutics, Inc. ALLR |
Mitchell P. Kopin | 17 4.200% |
17 (New Position) |
Filing History |
| 2023-04-19 5:14 pm Purchase |
2023-04-10 | 13G | SenesTech, Inc. SNES |
Mitchell P. Kopin | 1,284 4.990% |
1,284 (New Position) |
Filing History |
| 2023-04-14 4:24 pm Purchase |
2023-04-06 | 13G | Clearmind Medicine Inc. CMND |
Mitchell P. Kopin | 12,821 6.300% |
12,821 (New Position) |
Filing History |
| 2023-02-24 4:27 pm Unchanged |
2023-02-15 | 13G | Atlis Motor Vehicles, Inc. AMV |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-23 5:11 pm Purchase |
2023-02-14 | 13G | Top Ships Inc. TOPS |
Mitchell P. Kopin | 86,623 4.990% |
86,623 (New Position) |
Filing History |
| 2023-02-21 06:02 am Purchase |
2023-02-09 | 13G | Revelation Biosciences, Inc. REVB |
Mitchell P. Kopin | 385 4.990% |
385 (New Position) |
Filing History |
| 2023-02-17 4:43 pm Purchase |
2023-02-08 | 13G | OceanPal Inc. OP |
Mitchell P. Kopin | 137,109 9.990% |
137,109 (New Position) |
Filing History |